These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 30021382

  • 21. Hsa-miR-3178/RhoB/PI3K/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer.
    Gu J, Huang W, Wang X, Zhang J, Tao T, Zheng Y, Liu S, Yang J, Chen ZS, Cai CY, Li J, Wang H, Fan Y.
    Mol Cancer; 2022 May 10; 21(1):112. PubMed ID: 35538494
    [Abstract] [Full Text] [Related]

  • 22. Effects of ribosomal associated protein hnRNP D in gemcitabine-resistant pancreatic cancer.
    Wang C, Huang H.
    Biochem Biophys Res Commun; 2021 Nov 19; 579():181-187. PubMed ID: 34624736
    [Abstract] [Full Text] [Related]

  • 23. [Mechanism of SPARC-enhanced chemosensitivity of pancreatic cancer cells to gemcitabine].
    Zhang J, Jiang H, Mao Z, Wang X, Fan X, Liu Y, Wang Y.
    Zhonghua Zhong Liu Za Zhi; 2014 May 19; 36(5):335-40. PubMed ID: 25030587
    [Abstract] [Full Text] [Related]

  • 24. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient-derived xenograft tumors.
    Dhar D, Raina K, Kumar D, Wempe MF, Bagby SM, Pitts TM, Orlicky DJ, Agarwal C, Messersmith WA, Agarwal R.
    Mol Carcinog; 2020 Oct 19; 59(10):1227-1240. PubMed ID: 32816368
    [Abstract] [Full Text] [Related]

  • 25. miR-133a-3p suppresses cell proliferation, migration, and invasion and promotes apoptosis in esophageal squamous cell carcinoma.
    Yin Y, Du L, Li X, Zhang X, Gao Y.
    J Cell Physiol; 2019 Aug 19; 234(8):12757-12770. PubMed ID: 30537034
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA-200c overexpression inhibits chemoresistance, invasion and colony formation of human pancreatic cancer stem cells.
    Ma C, Huang T, Ding YC, Yu W, Wang Q, Meng B, Luo SX.
    Int J Clin Exp Pathol; 2015 Aug 19; 8(6):6533-9. PubMed ID: 26261532
    [Abstract] [Full Text] [Related]

  • 27. PVT1 Knockdown Inhibits Autophagy and Improves Gemcitabine Sensitivity by Regulating the MiR-143/HIF-1α/VMP1 Axis in Pancreatic Cancer.
    Liu YF, Luo D, Li X, Li ZQ, Yu X, Zhu HW.
    Pancreas; 2021 Feb 01; 50(2):227-234. PubMed ID: 33565800
    [Abstract] [Full Text] [Related]

  • 28. Chemosensitivity induced by down-regulation of microRNA-21 in gemcitabine-resistant pancreatic cancer cells by indole-3-carbinol.
    Paik WH, Kim HR, Park JK, Song BJ, Lee SH, Hwang JH.
    Anticancer Res; 2013 Apr 01; 33(4):1473-81. PubMed ID: 23564788
    [Abstract] [Full Text] [Related]

  • 29. Reduced miR-363-3p expression in non-small cell lung cancer is associated with gemcitabine resistance via targeting of CUL4A.
    Bian WG, Zhou XN, Song S, Chen HT, Shen Y, Chen P.
    Eur Rev Med Pharmacol Sci; 2019 Jan 01; 23(2):649-659. PubMed ID: 30720173
    [Abstract] [Full Text] [Related]

  • 30. Resistance to gemcitabine is mediated by the circ_0036627/miR-145/S100A16 axis in pancreatic cancer.
    Yu S, Wang M, Zhang H, Guo X, Qin R.
    J Cell Mol Med; 2024 Jun 01; 28(12):e18444. PubMed ID: 38924205
    [Abstract] [Full Text] [Related]

  • 31. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK.
    Patel GK, Khan MA, Bhardwaj A, Srivastava SK, Zubair H, Patton MC, Singh S, Khushman M, Singh AP.
    Br J Cancer; 2017 Feb 28; 116(5):609-619. PubMed ID: 28152544
    [Abstract] [Full Text] [Related]

  • 32. Role of miR-92a-3p/PTEN axis in regulation of pancreatic cancer cell proliferation and metastasis.
    Liu Y, Hu Q, Ao J, Li H, Li M.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar 28; 45(3):280-289. PubMed ID: 32386020
    [Abstract] [Full Text] [Related]

  • 33. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
    Zhang ZB, Liu N.
    Aging (Albany NY); 2021 Aug 30; 13(16):20820-20835. PubMed ID: 34461605
    [Abstract] [Full Text] [Related]

  • 34. Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63.
    Ozaki T, Nakamura M, Ogata T, Sang M, Yoda H, Hiraoka K, Sang M, Shimozato O.
    Oncotarget; 2016 Nov 01; 7(44):71937-71950. PubMed ID: 27713122
    [Abstract] [Full Text] [Related]

  • 35. Long Noncoding RNA HCP5 Regulates Pancreatic Cancer Gemcitabine (GEM) Resistance By Sponging Hsa-miR-214-3p To Target HDGF.
    Liu Y, Wang J, Dong L, Xia L, Zhu H, Li Z, Yu X.
    Onco Targets Ther; 2019 Nov 01; 12():8207-8216. PubMed ID: 31632071
    [Abstract] [Full Text] [Related]

  • 36. miR-153 enhances the therapeutic effect of gemcitabine by targeting Snail in pancreatic cancer.
    Liu F, Liu B, Qian J, Wu G, Li J, Ma Z.
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun 01; 49(6):520-529. PubMed ID: 28459992
    [Abstract] [Full Text] [Related]

  • 37. Quercetin induces apoptosis and enhances gemcitabine therapeutic efficacy against gemcitabine-resistant cancer cells.
    Liu ZJ, Xu W, Han J, Liu QY, Gao LF, Wang XH, Li XL.
    Anticancer Drugs; 2020 Aug 01; 31(7):684-692. PubMed ID: 32282368
    [Abstract] [Full Text] [Related]

  • 38. Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer.
    Uz M, Kalaga M, Pothuraju R, Ju J, Junker WM, Batra SK, Mallapragada S, Rachagani S.
    J Control Release; 2019 Jan 28; 294():237-246. PubMed ID: 30576747
    [Abstract] [Full Text] [Related]

  • 39. (3E,5E)-3,5-Bis(pyridin-3-methylene)-tetrahydrothiopyran-4-one enhances the inhibitory effect of gemcitabine on pancreatic cancer cells.
    Wu P, Wang X, Ma Y, Xu X, Liu W, Sheng Z, Chen M, Zhou R, Zhang K, Goodin S, Zheng X, Li D.
    Bioorg Chem; 2020 Aug 28; 101():104022. PubMed ID: 32599367
    [Abstract] [Full Text] [Related]

  • 40. Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells.
    Shen Y, Pan Y, Xu L, Chen L, Liu L, Chen H, Chen Z, Meng Z.
    Tumour Biol; 2015 Jun 28; 36(6):4525-34. PubMed ID: 25722110
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.